PREVLAR: Phase 2a Randomized Trial to Assess the Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Head and Neck Chemoradiotherapy - Concepedia

Concepedia

Publication | Open Access

PREVLAR: Phase 2a Randomized Trial to Assess the Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Head and Neck Chemoradiotherapy

DOI Full Paper Access

16

Citations

16

References

2023

Year

Marcelo Bonomi, Dukagjin Blakaj, Rafi Kabarriti, Kyle Colvett, Vinita Takiar, Matthew C. Biagioli, Voichita Bar‐Ad, Sharad Goyal, Brian C. Muzyka, Kenneth J. Niermann,

International Journal of Radiation Oncology*Biology*Physics

Abstract

Our results support the safety and feasibility of RRx-001 as an intervention to mitigate SOM. Additional studies are planned to confirm its efficacy.

References

	Year	Citations

Page 1